Vest that shocks heart back to life under scrutiny

NCT ID NCT05135403

Recruiting now Disease control Sponsor: Kestra Medical Technologies, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study follows over 5,000 people who are prescribed a wearable defibrillator vest to prevent sudden cardiac arrest. Researchers will analyze data from the device to see how often it successfully corrects dangerous heart rhythms and how often it delivers unnecessary shocks. The goal is to confirm the vest works well in everyday life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Wearable cardioverter defibrillator (WCD)
What this could lead to: If successful, this study could confirm that the wearable defibrillator reliably treats dangerous heart rhythms, helping prevent sudden cardiac arrest in at-risk patients.
What could go wrong: This is an observational registry study, not a controlled trial, so results may be influenced by real-world variability. The device may still deliver inappropriate shocks or fail to convert some arrhythmias.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUDDEN CARDIAC ARREST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Death, Sudden, Cardiac sudden cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUDDEN CARDIAC ARREST

Contacts and locations

Locations

University of Washington Medical Center
RECRUITING

Seattle, Washington, 98033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.